Rowan McEvoy, B.S.

Policy Lead
Acumen, LLC

Poster(s):

• (352) Safety of Ancestral Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST